PEP-device for Treatment of Swimming-induced Pulmonary Edema (SIPE)

Sponsor
Dalarna County Council, Sweden (Other)
Overall Status
Recruiting
CT.gov ID
NCT05227222
Collaborator
(none)
40
1
2
36.4
1.1

Study Details

Study Description

Brief Summary

In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of treatment with positive expiratory pressure device (PEP-device) compared to spontaneous recovery in patients with SIPE without hypoxia in the out-of-hospital environment.

Condition or Disease Intervention/Treatment Phase
  • Device: PEP-device
N/A

Detailed Description

Swimming induced pulmonary edema (SIPE) is an unusual condition affecting otherwise healthy swimmers. SIPE is characterized by acute onset of dyspnea and cough, excessive sputum and occasionally hemoptysis when swimming in open water. The condition usually resolves spontaneously within 48 hours, but may result in serious illness and require emergency care. Case reports describe acute treatment with or without oxygen in combination with diuretics, beta-agonist-inhalation or continuous positive airway pressure (CPAP). Evidence for optimal treatment strategy is lacking. Oxygen treatment might not be appropriate for patients with SIPE presenting without hypoxia. It is unknown if positive airway pressure accelerates recovery in SIPE.

This study intends to determine whether treatment with positive expiratory pressure (PEP) applied by PEP-device accelerates increase of oxygen saturation compared to spontaneous recovery in patients presenting with SIPE without hypoxia. The aim is to treat patients on site without involving hospital care. We study a large cohort of approximately 12 000 swimmers during Vansbrosimningen, Sweden's biggest annual open water event with a yearly incidence of SIPE about 0,4%.

Adult patients clinically diagnosed with SIPE and oxygen saturation ≥92% are randomly assigned to 2 groups: (1) PEP-device for 20 minutes or (2) control group with spontaneous recovery without active treatment for 20 minutes. Assessment with outcome measures is taken 10 minutes after intervention/control. Primary endpoint: oxygen saturation (%) by pulse oxymetry.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Positive Expiratory Pressure Device (PEP-device) for Treatment of Swimming Induced Pulmonary Edema (SIPE) - a Randomized Single-blinded Controlled Study
Actual Study Start Date :
Jul 2, 2022
Anticipated Primary Completion Date :
Jul 15, 2025
Anticipated Study Completion Date :
Jul 15, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: PEP-device

Positive expiratory pressure device: continuous treatment with PEP-device breathing air for 20 minutes followed by 10 minutes rest and assessment. Inspiration through nose/mouth, expiration through device.

Device: PEP-device
PEP-device

No Intervention: spontaneous recovery

Control group: Resting and breathing air for 20 + 10 minutes.

Outcome Measures

Primary Outcome Measures

  1. Absolute peripheral oxygen saturation (%) after treatment [after 20 min treatment followed by 10 min rest]

    Peripheral oxygen saturation % (continuous variable) measured by peripheral pulse oximetry

Secondary Outcome Measures

  1. Change in absolute peripheral oxygen saturation (%) before and after treatment [change before versus after 20 min treatment followed by 10 min rest]

    Change in peripheral oxygen saturation % (continuous variable) measured by pulse oximetry before and after treatment

  2. Recovery (yes/no) after treatment [after 20 min treatment followed by 10 min rest]

    Recovery, defined by "peripheral oxygen saturation >95% after treatment" or no recovery, defined by "peripheral oxygen saturation ≤95% after treatment"

  3. Interstitial syndrome assessed by lung ultrasound (yes/no) after treatment [after 20 min treatment followed by 10 min rest]

    Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Bilateral or unilateral presence of two or more positive regions define positive interstitial syndrome

  4. Absolute number of regions presenting B-lines on lung ultrasound after treatment [after 20 min treatment followed by 10 min rest]

    Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Assessment of the total number of positive regions.

  5. Change in absolute number of regions presenting B-lines on lung ultrasound before and after treatment [change before versus after 20 min treatment followed by 10 min rest]

    Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Assessment of the total number of positive regions. Change in absolute number of regions presenting B-lines on lung ultrasound before and after treatment

  6. Change in patient reported outcome measures before and after treatment [change before versus after 20 min treatment followed by 10 min rest]

    Six different patient reported outcome measures assessed by numerical rating scale (NRS; min-max 0-10): cough, sputum, air hunger, breathing effort, tightness in chest, anxiousness. The patients will assess symptoms prior to and after treatment

  7. Admission to hospital (yes/no) [1 hour]

    Admission to hospital within or after a maximal treatment time of 1 hour

  8. Total treatment time [1 hour]

    Total treatment time until oxygen saturation ≥96% is reached

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • clinical diagnosis of swimming induced pulmonary edema (SIPE) with need of acute treatment

  • peripheral oxygen saturation ≥92%

  • 18 years or older

  • informed consent

Exclusion Criteria:
  • declined consent

  • suspected acute coronary syndrome

  • severe asthma diagnosed together with pulmonary edema with requirement of beta-agonist-inhalation prior to treatment of pulmonary edema

  • hemodynamic instability or decreased consciousness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center of Clinical Research Dalarna Falun Sweden 79182

Sponsors and Collaborators

  • Dalarna County Council, Sweden

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maria Hårdstedt, Dr. Maria Hårdstedt, PhD, Specialist Internal Medicine, Dalarna County Council, Sweden
ClinicalTrials.gov Identifier:
NCT05227222
Other Study ID Numbers:
  • SIPE PEP-device001
First Posted:
Feb 7, 2022
Last Update Posted:
Jul 6, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maria Hårdstedt, Dr. Maria Hårdstedt, PhD, Specialist Internal Medicine, Dalarna County Council, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022